Viral Molecular High Density Sequencing Core
The viral molecular high density sequencing (VMHDS) core offers services to assist in evaluating cell and gene therapies (lentivirus, MLV, AAV, CRISPR). We are currently assisting with over 20 gene therapy clinical trials globally across academic and corporate institutions, both as exploratory and safety endpoints, and have contributed to more than 80 publications. We are experts in molecular analyses, custom informatics and assisting with regulatory approval documents. See below for a list of services offered, or reach out for custom requests. Email Aoife Doto, Technical Director, for more information. Click here to access our core iLabs website and request services.
Please see our FAQ page for additional information.
| Director | Frederic Bushman, PhD | bushman@pennmedicine.upenn.edu |
| Technical Director | Aoife Doto, PhD | rochea@pennmedicine.upenn.edu |
| Bioinformatic Director | John Everett, PhD | everj@pennmedicine.upenn.edu |
| Business Manager | James Burns |
